Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-04 2:15 pm Purchase | 13G | ZEVRA THERAPEUTICS INC. ZVRA | VANGUARD GROUP INC | 2,756,061 5.230% | 2,756,061 (New Position) | View |
| 2024-02-14 4:51 pm Purchase | 13G | ZEVRA THERAPEUTICS INC. ZVRA | Nantahala Capital Management LLC | 2,453,405 6.200% | 2,453,405 (New Position) | View |
| 2024-01-29 5:25 pm Purchase | 13G | ZEVRA THERAPEUTICS INC. ZVRA | BlackRock Inc. BLK | 2,410,289 5.800% | 1,557,440 (+182.62%) | View |
| 2022-07-08 4:57 pm Sale | 13G | ZEVRA THERAPEUTICS INC. ZVRA | BlackRock Inc. BLK | 852,849 2.500% | -1,382,693 (-61.85%) | View |
| 2022-02-04 4:12 pm Purchase | 13G | ZEVRA THERAPEUTICS INC. ZVRA | BlackRock Inc. BLK | 2,235,542 6.300% | 2,235,542 (New Position) | View |
| 2022-01-12 4:03 pm Sale | 13G | ZEVRA THERAPEUTICS INC. ZVRA | Braun Samuel J | 3,021,660 8.600% | -355,900 (-10.54%) | View |
| 2022-01-11 10:30 am Sale | 13G | ZEVRA THERAPEUTICS INC. ZVRA | Empery Asset Management LP | 801,670 2.220% | -428,330 (-34.82%) | View |
| 2021-12-01 08:25 am Purchase | 13D | ZEVRA THERAPEUTICS INC. ZVRA | Braun Samuel J | 3,377,560 9.600% | 222,560 (+7.05%) | View |
| 2021-05-17 4:43 pm Purchase | 13G | ZEVRA THERAPEUTICS INC. ZVRA | Braun Samuel J | 3,155,000 11.100% | 1,098,500 (+53.42%) | View |
| 2021-04-19 5:12 pm Purchase | 13G | ZEVRA THERAPEUTICS INC. ZVRA | Braun Samuel J | 2,056,500 7.200% | 2,056,500 (New Position) | View |
| 2021-03-09 10:38 am Sale | 13G | ZEVRA THERAPEUTICS INC. ZVRA | Mangless Daniel John | 700,000 3.700% | -1,300,000 (-65.00%) | View |
| 2021-02-16 07:01 am Purchase | 13G | ZEVRA THERAPEUTICS INC. ZVRA | Delaware Street Capital Master Fund L.P. | 159,364 3.400% | 159,364 (New Position) | View |
| 2021-02-12 2:23 pm Sale | 13G | ZEVRA THERAPEUTICS INC. ZVRA | Auctus Fund LLC | 450,000 2.380% | -550,000 (-55.00%) | View |
| 2021-02-11 8:14 pm Purchase | 13G | ZEVRA THERAPEUTICS INC. ZVRA | Mickle Travis C | 227,545 4.900% | 227,545 (New Position) | View |
| 2021-02-05 2:04 pm Purchase | 13G | ZEVRA THERAPEUTICS INC. ZVRA | Auctus Fund LLC | 1,000,000 8.580% | 1,000,000 (New Position) | View |
| 2021-01-14 09:00 am Purchase | 13G | ZEVRA THERAPEUTICS INC. ZVRA | Empery Asset Management LP | 1,230,000 9.990% | 1,230,000 (New Position) | View |
| 2020-02-14 4:55 pm Purchase | 13G | ZEVRA THERAPEUTICS INC. ZVRA | Mickle Travis C | 3,252,280 8.900% | 516,697 (+18.89%) | View |
| 2020-02-14 10:25 am Sale | 13G | ZEVRA THERAPEUTICS INC. ZVRA | Alyeska Investment Group L.P. | 0 0.000% | -1,825,000 (Position Closed) | View |
| 2020-02-11 3:52 pm Purchase | 13G | ZEVRA THERAPEUTICS INC. ZVRA | Mangless Daniel John | 2,000,000 6.020% | 500,000 (+33.33%) | View |